STOCK TITAN

Guided Therapeutics, Inc. - $GTHP STOCK NEWS

Welcome to our dedicated page for Guided Therapeutics news (Ticker: $GTHP), a resource for investors and traders seeking the latest updates and insights on Guided Therapeutics stock.

Guided Therapeutics Inc. (GTHP) is a pioneering medical technology company focused on improving women's healthcare. The company is primarily known for its development of the LuViva® Advanced Cervical Scan, a non-invasive device designed for the early detection of cervical disease, including pre-cancerous conditions. This innovative technology aims to provide more accurate and immediate results compared to traditional Pap smears and HPV tests.

Guided Therapeutics is headquartered in Peachtree Corners, Georgia, and has established significant partnerships to enhance its research and development capabilities. Recently, the company has expanded its reach through various international collaborations, enabling broader access to its life-saving technology.

The financial health of Guided Therapeutics shows a commitment to continuous investment in R&D, ensuring they stay at the forefront of medical technology. Their product pipeline includes enhancements to the LuViva® system and other potential diagnostic tools that could revolutionize patient care.

The company's strategic vision emphasizes the importance of preventive healthcare, aiming to reduce the global burden of cervical cancer. With a solid foundation in medical research and a commitment to innovation, Guided Therapeutics Inc. is poised to make a significant impact on women's health worldwide.

Rhea-AI Summary
Guided Therapeutics, Inc. (GTHP) announces final stages of clinical data report for LuViva Advanced Cervical Scan approval in China. Expected approval by Chinese NMPA with positive feedback from prominent doctors. Commercialization payments from Chinese partner to exceed $4 million in 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
17.65%
Tags
-
Rhea-AI Summary
Guided Therapeutics, Inc. (OTCQB: GTHP) announced the completion of a clinical trial for marketing and sales approval of the LuViva Advanced Cervical Scan by the Chinese National Medical Products Administration (NMPA). The study, involving about 450 women, was conducted at prestigious medical institutions, including Shandong University, Fudan University, and Peking University. The study was led by prominent doctors, and the results will be filed with NMPA within the next 90 days, triggering purchase order payments to Guided Therapeutics of approximately $2.2 million, with more significant orders expected in 2024 and beyond.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-16%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.17%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
9.26%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
47.41%
Tags
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.51%
Tags
none
-
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.67%
Tags

FAQ

What is Guided Therapeutics Inc. best known for?

Guided Therapeutics Inc. is best known for developing the LuViva® Advanced Cervical Scan, a non-invasive device for early detection of cervical disease.

Where is Guided Therapeutics Inc. located?

The company is headquartered in Peachtree Corners, Georgia.

What recent achievements has Guided Therapeutics Inc. made?

Recently, the company has expanded its reach through various international collaborations to enhance global access to its technology.

How is the financial health of Guided Therapeutics Inc.?

The company continuously invests in research and development, indicating a strong commitment to innovation and sustained growth.

What are the core business operations of Guided Therapeutics Inc.?

The core business operations include developing and marketing medical devices for early detection of cervical disease, particularly the LuViva® Advanced Cervical Scan.

What partnerships has Guided Therapeutics Inc. formed recently?

The company has established significant partnerships internationally to enhance its research, development, and distribution capabilities.

What is the LuViva® Advanced Cervical Scan?

The LuViva® Advanced Cervical Scan is a non-invasive diagnostic device for the early detection of cervical disease, providing accurate and immediate results.

What is the company's vision?

Guided Therapeutics Inc. aims to reduce the global burden of cervical cancer by emphasizing preventive healthcare and innovative medical technology.

What products are in the pipeline for Guided Therapeutics Inc.?

The company is working on enhancements to the LuViva® system and exploring other diagnostic tools to improve patient care.

Guided Therapeutics, Inc.

OTC:GTHP

GTHP Rankings

GTHP Stock Data

5.09M
23.73M
43.7%
7.34%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
United States of America
Norcross